A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

C. Duran; A. Burbank; K. Mills; H. Duckworth; M. Aleman; Matthew Kesic; D. Peden; Y. Pan; H. Zhou; M. L. Hernandez

doi:10.1186/s12931-016-0406-8

A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

C. Duran, A. Burbank, K. Mills, H. Duckworth, M. Aleman, Matthew Kesic, D. Peden, Y. Pan, H. Zhou, M. L. Hernandez

Campbell University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Respiratory Research
Volume	17
DOIs	https://doi.org/10.1186/s12931-016-0406-8
State	Published - Jul 22 2016

Disciplines

Medicine and Health Sciences

Access to Document

10.1186/s12931-016-0406-8License: Unspecified

A proof-of-concept clinical study examining the NRF2 activator suFinal published version, 489 KBLicense: Unspecified

Cite this

@article{afb1b8f4291747e9b6854e1777664cec,

title = "A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation",

author = "C. Duran and A. Burbank and K. Mills and H. Duckworth and M. Aleman and Matthew Kesic and D. Peden and Y. Pan and H. Zhou and Hernandez, {M. L.}",

year = "2016",

month = jul,

day = "22",

doi = "10.1186/s12931-016-0406-8",

language = "American English",

volume = "17",

journal = "Respiratory Research",

}

TY - JOUR

T1 - A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

AU - Duran, C.

AU - Burbank, A.

AU - Mills, K.

AU - Duckworth, H.

AU - Aleman, M.

AU - Kesic, Matthew

AU - Peden, D.

AU - Pan, Y.

AU - Zhou, H.

AU - Hernandez, M. L.

PY - 2016/7/22

Y1 - 2016/7/22

UR - https://cufind.campbell.edu/physician_assistant_program/72

U2 - 10.1186/s12931-016-0406-8

DO - 10.1186/s12931-016-0406-8

M3 - Article

VL - 17

JO - Respiratory Research

JF - Respiratory Research

ER -

A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation

Disciplines

Access to Document

Other files and links

Cite this